SE8702941L - PHARMACEUTICAL, N-ACETYL-CYSTEIN-CONTAINING, WATER-SOLUBLE COMPOSITION - Google Patents
PHARMACEUTICAL, N-ACETYL-CYSTEIN-CONTAINING, WATER-SOLUBLE COMPOSITIONInfo
- Publication number
- SE8702941L SE8702941L SE8702941A SE8702941A SE8702941L SE 8702941 L SE8702941 L SE 8702941L SE 8702941 A SE8702941 A SE 8702941A SE 8702941 A SE8702941 A SE 8702941A SE 8702941 L SE8702941 L SE 8702941L
- Authority
- SE
- Sweden
- Prior art keywords
- water
- pharmaceutical
- cystein
- acetyl
- weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 108010011485 Aspartame Proteins 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 1
- 229960004308 acetylcysteine Drugs 0.000 abstract 1
- 239000000605 aspartame Substances 0.000 abstract 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 abstract 1
- 229960003438 aspartame Drugs 0.000 abstract 1
- 235000010357 aspartame Nutrition 0.000 abstract 1
- 230000001013 cariogenic effect Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 230000000510 mucolytic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A pharmaceutical composition in the form of water-soluble granules comprises: N-Acetylcysteine 10-20% by weight Aspartame 2 - 3% by weight Sorbitol 67-78% by weight Flavouring Agent About 10% by weight The composition has mucolytic activity, is non-cariogenic, and suitable for diabetics. <IMAGE>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH2974/86A CH666814A5 (en) | 1986-07-24 | 1986-07-24 | WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN. |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8702941D0 SE8702941D0 (en) | 1987-07-23 |
SE8702941L true SE8702941L (en) | 1988-01-25 |
SE500493C2 SE500493C2 (en) | 1994-07-04 |
Family
ID=4245819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8702941A SE500493C2 (en) | 1986-07-24 | 1987-07-23 | Pharmaceutical, water-soluble composition containing N-acetyl-cysteine, aspartame and sorbitol |
Country Status (8)
Country | Link |
---|---|
BE (1) | BE1000168A3 (en) |
CH (1) | CH666814A5 (en) |
DE (1) | DE3723734A1 (en) |
FR (1) | FR2601875B1 (en) |
GB (1) | GB2192789B (en) |
IT (1) | IT1222103B (en) |
NL (1) | NL194154C (en) |
SE (1) | SE500493C2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1217445B (en) * | 1988-04-29 | 1990-03-22 | Altergon Sa | SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING ACETYLCISTEIN |
CH674940A5 (en) * | 1988-05-05 | 1990-08-15 | Ibsa Inst Biochimique Sa | |
DE3909049A1 (en) * | 1989-03-18 | 1990-09-20 | Arthur Boskamp | PREPARATION AND THEIR USE |
US5296500A (en) * | 1991-08-30 | 1994-03-22 | The Procter & Gamble Company | Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy |
IT1256616B (en) * | 1992-12-02 | 1995-12-12 | Zambon Spa | SYRUP CONTAINING N-ACETYL-CISTEIN |
GB9226729D0 (en) * | 1992-12-22 | 1993-02-17 | Wellcome Found | Therapeutic combination |
DE4406261C2 (en) * | 1993-08-31 | 1996-07-04 | Deutsches Krebsforsch | Use of thiol compounds to reduce body fat |
DE4329857C2 (en) * | 1993-09-03 | 1995-08-24 | Deutsches Krebsforsch | Connection to strengthen the immune system and immune reactions |
BE1007926A3 (en) * | 1994-01-31 | 1995-11-21 | Zambon Int Pharma | Pharmaceutical composition containing n-acetyl-cysteine. |
US5451405A (en) * | 1994-04-25 | 1995-09-19 | Chesebrough-Pond's Usa Co. | Skin treatment composition |
WO2000018392A1 (en) * | 1998-09-25 | 2000-04-06 | Glycox Corporation Limited | Fructosamine oxidase: antagonists and inhibitors |
CN1320160A (en) | 1998-09-25 | 2001-10-31 | 格利科克斯有限公司 | Fructosamine oxidase assay method and materials |
EP1293251A1 (en) * | 2001-09-14 | 2003-03-19 | Holland Sweetener Company V.o.F. | Process for the production of alpha-L-aspartyl-l-phenylalanine methyl ester powder |
CN1649577A (en) | 2002-03-08 | 2005-08-03 | 普罗特米克斯公司 | Preventing and/or treating cardiovascular disease and/or associated heart failure |
EP1539129A4 (en) | 2002-08-20 | 2006-03-08 | Protemix Corp Ltd | Dosage forms and related therapies |
DK1778618T3 (en) | 2004-07-19 | 2014-03-10 | Philera New Zealand Ltd | Synthesis of triethylenetetramines |
GR1007236B (en) * | 2009-12-07 | 2011-04-08 | Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, | New pharmaceutical composition of n-acetylcysteine granules and production method thereof |
IT1399492B1 (en) * | 2010-04-13 | 2013-04-19 | Alpex Pharma Sa | EFFERVESCENT PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCISTEIN. |
CN103142505B (en) * | 2013-03-29 | 2015-03-11 | 山东罗欣药业集团股份有限公司 | Acetylcysteine composition granules and preparation method thereof |
EP3505153B1 (en) | 2017-12-31 | 2021-03-24 | Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. | A pharmaceutical composition comprising acetylcysteine which is free of methylparaben and propylparaben |
CN113559078A (en) * | 2021-07-02 | 2021-10-29 | 安徽省先锋制药有限公司 | Preparation method of acetylcysteine effervescent tablets |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1617638A1 (en) * | 1967-05-24 | 1971-05-13 | Miles Lab | Tablet binder |
CH646843A5 (en) * | 1982-02-17 | 1984-12-28 | Xyrofin Ag | Sugar substitute, method for its production, and its use |
DE3317530A1 (en) * | 1983-05-13 | 1984-11-15 | Dietrich Dr.med. Sta. Eulalia Ibiza Reichert | Antisnoring composition |
AU574360B2 (en) * | 1983-05-13 | 1988-07-07 | Reichert, D. | Antisnoring agent |
DE3317558A1 (en) * | 1983-05-13 | 1984-11-15 | Dietrich Dr.med. Sta. Eulalia Ibiza Reichert | Oral antisnoring composition |
IT1170268B (en) * | 1983-12-21 | 1987-06-03 | Zambon Spa | USE OF ACETYLCISTEIN TO REDUCE THE INCREASE IN THE PROLIEFERATION OF THE BASAL CELLS OF THE RESPIRATORY THRACHEO-BRONCHIAL EPITHELIUM INDUCED BY TOBACCO SMOKE IN MAMMALS |
DE3514995A1 (en) * | 1985-04-25 | 1986-10-30 | Protopharma Ltd., 7831 Malterdingen | Use of sulfhydryl pharmaceuticals for combating damage to the gastric mucosa |
-
1986
- 1986-07-24 CH CH2974/86A patent/CH666814A5/en not_active IP Right Cessation
-
1987
- 1987-07-17 DE DE19873723734 patent/DE3723734A1/en active Granted
- 1987-07-22 FR FR878710367A patent/FR2601875B1/en not_active Expired - Lifetime
- 1987-07-23 SE SE8702941A patent/SE500493C2/en not_active IP Right Cessation
- 1987-07-23 BE BE8700817A patent/BE1000168A3/en not_active IP Right Cessation
- 1987-07-23 NL NL8701744A patent/NL194154C/en not_active IP Right Cessation
- 1987-07-23 IT IT21410/87A patent/IT1222103B/en active
- 1987-07-24 GB GB8717581A patent/GB2192789B/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IT8721410A0 (en) | 1987-07-23 |
FR2601875B1 (en) | 1992-02-21 |
FR2601875A1 (en) | 1988-01-29 |
CH666814A5 (en) | 1988-08-31 |
NL194154C (en) | 2001-08-03 |
NL8701744A (en) | 1988-02-16 |
GB8717581D0 (en) | 1987-09-03 |
GB2192789A (en) | 1988-01-27 |
NL194154B (en) | 2001-04-02 |
IT1222103B (en) | 1990-08-31 |
SE500493C2 (en) | 1994-07-04 |
DE3723734C2 (en) | 1992-05-21 |
DE3723734A1 (en) | 1988-02-04 |
SE8702941D0 (en) | 1987-07-23 |
BE1000168A3 (en) | 1988-07-05 |
GB2192789B (en) | 1990-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8702941D0 (en) | PHARMACEUTICAL, N-ACETYL-CYSTEIN-CONTAINING, WATER-SOLUBLE COMPOSITION | |
SE8702940L (en) | PHARMACEUTICAL, N-ACETYL-CYSTEIN-CONTAINING, WATER-SOLUBLE COMPOSITION | |
IT8520998A0 (en) | GRANULE CONTAINING PHYSIOLOGICALLY ACTIVE SUBSTANCE, METHOD FOR ITS PREPARATION AND ITS USE. | |
IT8548373A0 (en) | PROPOSED AMINO DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES | |
SE8901671L (en) | LAEKEMEDELSADSORBAT | |
IT8847556A0 (en) | PEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES | |
IT1217445B (en) | SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING ACETYLCISTEIN | |
MX9101009A (en) | PHARMACEUTICAL COMPOSITION CONTAINING FURAN DERIVATIVES AND PROCEDURE FOR ITS PREPARATION | |
ES2060163T3 (en) | PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL. | |
IT7950847A0 (en) | AMINO DERIVATIVES EQUIPPED WITH PHARMACOLOGICAL ACTIVE TAXES AND PROCEDURE FOR THEIR PREPARATION | |
ATE65395T1 (en) | ACETYLCYSTEINE CONTAINING SOLID WATER-SOLUBLE MEDICINAL PRODUCT. | |
GB2021409A (en) | Pharmaceutical composition | |
DE69017969D1 (en) | Fragrance composition containing 2-cyclohexylpropionic acid or derivatives thereof. | |
FI821324L (en) | OXAZOLDERIVAT | |
IT8026233A0 (en) | DERIVATIVE OF N-ACETYL-CYSTEINE WITH THERAPEUTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS. | |
GB2037761B (en) | Fungicidally and nematocidally active 1,2,4-thiadiazole-2-carboxylic acid derivatives and their manufacture and use | |
DK179786D0 (en) | (-) - 1BETA-ETHYL-1ALFA-HYDROXYLMETHYL-1,2,3,4,6,7,12,12BALFA-OCTA-HYDROINDOLO (2,3-A) QUINOLIZIN AND ACID ADDITION SALTS THEREOF, THEIR PREPARATION AND USE AS PHARMACEUTICAL | |
IT7824637A0 (en) | SODIUM SALT OF MERCAPTOPIONYLGLYCINE, PROCESS FOR ITS PREPARATION AND ITS THERAPEUTIC USES. | |
BR7904458A (en) | COMPOSITION FOR USE IN BAIT FOR COMBATING SYNANTROPY FLIES, PROCESS OF OBTAINING THE BAIT AND ITS USE | |
IT8249771A0 (en) | CYCLOHEXANONE DERIVATIVES HAVING HERBICANT ACTIVITY, AND PROCEDURE FOR THEIR PREPARATION | |
IE782515L (en) | Treating diarrhoea | |
JPS52120132A (en) | Remedies for nephric diseases | |
JPS53127432A (en) | Novel physiologically active substance, anthglutin, and its preparation | |
IT7823016A0 (en) | PHARMACEUTICAL COMPOUND WITH IMPROVED MUCOLYTIC ACTIVITY AND FLUIDIFYING OF MUCOSAL SECRETIONS. | |
SU555945A1 (en) | The way to deal with cracks on products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |